Detalhe da pesquisa
1.
Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing's sarcoma.
Appl Microbiol Biotechnol
; 100(9): 3949-63, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-26685854
2.
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas.
BMC Cancer
; 14: 137, 2014 Feb 27.
Artigo
Inglês
| MEDLINE | ID: mdl-24575739
3.
BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
Nat Genet
; 30(1): 48-58, 2002 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-11753385
4.
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells.
J Cell Biochem
; 113(5): 1704-13, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22212957
5.
BCR/ABL activates mdm2 mRNA translation via the La antigen.
Cancer Cell
; 3(2): 145-60, 2003 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-12620409
6.
Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity.
Mol Cancer Ther
; 21(1): 58-69, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34667115
7.
The biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region, not on specificity of the DNA binding domain.
J Biol Chem
; 285(40): 30837-50, 2010 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20659895
8.
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma.
J Cell Commun Signal
; 14(3): 335-347, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32504411
9.
Elongation Factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility.
Mol Cancer
; 8: 58, 2009 Aug 03.
Artigo
Inglês
| MEDLINE | ID: mdl-19646290
10.
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients.
Clin Cancer Res
; 14(11): 3248-53, 2008 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18519749
11.
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy.
Mol Cancer Ther
; 17(9): 1881-1892, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29959201
12.
Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells.
Mol Cell Biol
; 24(12): 5421-33, 2004 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-15169904
13.
hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.
Mol Cell Biol
; 22(7): 2255-66, 2002 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-11884611
14.
CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
Oncotarget
; 7(48): 79925-79942, 2016 Nov 29.
Artigo
Inglês
| MEDLINE | ID: mdl-27835596
15.
CD99 triggering in Ewing sarcoma delivers a lethal signal through p53 pathway reactivation and cooperates with doxorubicin.
Clin Cancer Res
; 21(1): 146-56, 2015 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25501132
16.
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.
J Bone Miner Res
; 29(5): 1295-309, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24677094
17.
The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform.
Neoplasia
; 14(7): 634-43, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22904680
18.
NVP-BEZ235 as a new therapeutic option for sarcomas.
Clin Cancer Res
; 16(2): 530-40, 2010 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20068094
19.
Effects of C/EBPalpha and C/EBPbeta in BCR/ABL-expressing cells: differences and similarities.
Cell Cycle
; 5(12): 1254-7, 2006 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-16760662
20.
Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha.
Blood
; 108(4): 1353-62, 2006 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16670262